S2GdeltaHR2-presenting I3-01v9 self-assembling protein nanoparticle (Ufovax)

N/A

Report date: 2025/01/26 17:10:36

Base Information

Drug NameS2GdeltaHR2-presenting I3-01v9 self-assembling protein nanoparticle (Ufovax)
Drug Alias NameCOVID-19 vaccine (Ufovax)SARS-CoV-2 vaccine (Ufovax)COVID-19 VLP vaccine (Ufovax)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUvax Bio LLC
China Registration ClassN/A

Develop Information

Active CompaniesUvax Bio LLC
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A